Anupam Aditi, MD
Internal Medicine · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
Offices
1 location · Genesis Healthcare Partners PC · 232 clinicians in this group
Hospitals listed: Ahmc Seton Medical Center · Chinese Hospital · Mills-Peninsula Medical Center · UCSF Health Hyde Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aditi’s office at (650) 756-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Chinese HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Chinese Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 104 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.64 to 1.61) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 766 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.13 (0.4 to 3.85) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.57 to 4.02) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.72 (0 to 18.54) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.1) · 478 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (160 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$79,198
Medicare paid this office $79,198 for 236 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $10,356 | $142 |
| Return visit (30+ min) | 74 | $10,338 | $109 |
| New patient visit (45+ min) | 47 | $6,799 | $145 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $5,190 | $46 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 17 | $4,390 | $220 |
See all 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $10,356 | $142 |
| Return visit (30+ min) | 74 | $10,338 | $109 |
| New patient visit (45+ min) | 47 | $6,799 | $145 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $5,190 | $46 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 17 | $4,390 | $220 |
| Critical care, first 30-74 minutes | 15 | $4,045 | $184 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $3,665 | $59 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,124 | $195 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,108 | $86 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,797 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,304 | $105 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,692 | $154 |
| New patient visit (30+ min) | 12 | $1,102 | $92 |
| Short return visit (20+ min) | 12 | $1,063 | $82 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,009 | $67 |
Procedures Medicare counted
| Colonoscopy | 63 | More than 69% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 159 | More than 86% of doctors who do this |
Who their Medicare patients are
236 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 18% · Women 58% · Also on Medicaid 42% · Health risk score 1.89. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 39% · Coronary heart disease 37% · Heart failure 31% · Atrial fibrillation 23% · Depression 22% · Dementia 19% · Cancer 17% · COPD 12% · Stroke 12%.
The office billed $470,645, Medicare allowed $102,457 and paid $79,198; for 712 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 236 | 712 | 75 | 1.89 | $470,645 | $79,198 |
| 2023 | 251 | 680 | 76 | 1.83 | $454,985 | $77,129 |
| 2022 | 283 | 814 | 76 | 1.66 | $443,816 | $105,376 |
| 2021 | 213 | 786 | 75 | 1.71 | $330,301 | $96,630 |
| 2020 | 237 | 716 | 76 | 2.04 | $327,051 | $93,867 |
| 2019 | 278 | 1,009 | 76 | 1.78 | $315,574 | $116,022 |
| 2018 | 198 | 720 | 74 | 2.49 | $197,575 | $71,186 |
| 2017 | 87 | 272 | 74 | 2.46 | $104,595 | $30,140 |
| 2013 | 34 | 75 | 70 | 3.08 | $28,572 | $6,180 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $12,344 | $142 |
| Return visit (30+ min) | 77 | $11,570 | $106 |
| New patient visit (45+ min) | 53 | $7,170 | $135 |
| Critical care, first 30-74 minutes | 18 | $3,888 | $177 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $3,440 | $104 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $2,994 | $150 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 12 | $2,810 | $216 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $2,781 | $185 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,427 | $128 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,395 | $218 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,215 | $96 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,366 | $91 |
2022: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $15,616 | $163 |
| Return visit (30+ min) | 91 | $12,648 | $108 |
| New patient visit (45+ min) | 65 | $9,264 | $143 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 16 | $7,441 | $372 |
| Critical care, first 30-74 minutes | 28 | $6,414 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,516 | $90 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $4,950 | $171 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 24 | $4,680 | $180 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,326 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,913 | $224 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,461 | $189 |
| Biopsy of large bowel using a flexible endoscope | 15 | $2,351 | $157 |
| Incision of pancreatic outlet using a flexible endoscope | 16 | $1,350 | $84 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 22 | $98 | $4 |
2021: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $14,528 | $173 |
| Return visit (30+ min) | 79 | $11,861 | $107 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 15 | $8,480 | $404 |
| New patient visit (45+ min) | 41 | $5,559 | $136 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 25 | $5,325 | $130 |
| Critical care, first 30-74 minutes | 14 | $5,023 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,432 | $92 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,206 | $200 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,101 | $94 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,654 | $166 |
| Long return visit (40+ min) | 11 | $2,629 | $164 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,409 | $201 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,316 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,183 | $64 |
| Biopsy of large bowel using a flexible endoscope | 13 | $1,520 | $117 |
| Incision of pancreatic outlet using a flexible endoscope | 14 | $1,051 | $70 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $81 | $5 |
2020: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $13,083 | $182 |
| Return visit (30+ min) | 77 | $10,108 | $94 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 17 | $8,725 | $379 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 37 | $8,325 | $177 |
| Critical care, first 30-74 minutes | 20 | $8,084 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,195 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,042 | $92 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $3,472 | $204 |
| New patient visit (45+ min) | 26 | $3,220 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,973 | $124 |
| Incision of pancreatic outlet using a flexible endoscope | 25 | $1,984 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $1,857 | $81 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,782 | $149 |
| Short return visit (20+ min) | 15 | $1,094 | $61 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 24 | $122 | $5 |
2019: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $11,318 | $65 |
| Return visit (30+ min) | 79 | $11,032 | $98 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 36 | $9,163 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,820 | $180 |
| Critical care, first 30-74 minutes | 19 | $8,565 | $195 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $7,880 | $113 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 15 | $6,345 | $423 |
| New patient visit (45+ min) | 42 | $5,840 | $139 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | $5,715 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $4,816 | $93 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $4,575 | $176 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,576 | $223 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $3,382 | $211 |
| Short return visit (20+ min) | 38 | $2,943 | $67 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,793 | $127 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,028 | $184 |
| New patient visit (30+ min) | 21 | $1,819 | $87 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,546 | $141 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,151 | $34 |
| Incision of pancreatic outlet using a flexible endoscope | 23 | $1,118 | $43 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 64 | $312 | $5 |
2018: 18 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,250 | $113 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 14 | $6,876 | $404 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 66 | $6,242 | $34 |
| Return visit (30+ min) | 32 | $4,411 | $100 |
| New patient visit (45+ min) | 29 | $3,996 | $138 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 17 | $3,636 | $165 |
| Critical care, first 30-74 minutes | 12 | $3,495 | $194 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $3,244 | $154 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $3,053 | $218 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,723 | $105 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,640 | $220 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,212 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,177 | $62 |
| New patient visit (30+ min) | 23 | $2,004 | $87 |
| Biopsy of large bowel using a flexible endoscope | 15 | $1,744 | $116 |
| Short return visit (20+ min) | 26 | $1,448 | $54 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,345 | $103 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 51 | $267 | $5 |
2017: 8 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,411 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,320 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,984 | $180 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,490 | $106 |
| New patient visit (30+ min) | 14 | $1,212 | $87 |
| Return visit (30+ min) | 11 | $1,211 | $101 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $1,159 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $110 | $5 |
2013: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,429 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,448 | $63 |
Medicaid work
$331 in 2023
Medicaid paid $331 for 16 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 16 | $331 |
| 2023 | 16 | 1 | 16 | $331 |
| 2022 | 51 | 2 | 15 | $1,626 |
| 2021 | 68 | 2 | 16 | $1,676 |
| 2019 | 146 | 3 | 22 | $4,325 |
See the largest Medicaid services in earlier years
2022
| 1ST HOSP IP/OBS HIGH 75 | 12 | $1,109 |
| Return visit (30+ min) | 39 | $518 |
2021
| 1ST HOSP IP/OBS HIGH 75 | 28 | $1,135 |
| Return visit (30+ min) | 40 | $541 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $2,502 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 31 | $1,234 |
| Return visit (30+ min) | 26 | $589 |
Drugs they prescribed that Part D paid
$470,121
Pharmacies billed $470,121 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 304) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
190 generic and 114 brand-name prescriptions · $470,121 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Zenpep | 31 | $223,119 | $7,197 |
| Creon | 17 | $67,246 | $3,956 |
| Ursodiol | 11 | $3,440 | $313 |
| Suflave | 19 | $2,336 | $123 |
| Plenvu | 18 | $2,312 | $128 |
See all 9 drugs
| Zenpep | 31 | $223,119 | $7,197 |
| Creon | 17 | $67,246 | $3,956 |
| Ursodiol | 11 | $3,440 | $313 |
| Suflave | 19 | $2,336 | $123 |
| Plenvu | 18 | $2,312 | $128 |
| Pantoprazole | 42 | $963 | $23 |
| Omeprazole | 36 | $404 | $11 |
| Gavilyte-C | 17 | $354 | $21 |
| Famotidine | 12 | $26 | $2 |
Year by year
| 2024 | 304 | 135 | 0% (0) | 38% | $470,121 |
| 2023 | 318 | 136 | 0% (0) | 44% | $329,262 |
| 2022 | 271 | 123 | 0% (0) | 35% | $265,501 |
| 2021 | 256 | 112 | 0% (0) | 30% | $152,524 |
| 2020 | 206 | 83 | 0% (0) | 21% | $151,099 |
| 2019 | 242 | 110 | 0% (0) | 33% | $91,391 |
| 2018 | 178 | 94 | 0% (0) | 30% | $52,525 |
| 2017 | 47 | 26 | 0% (0) | None | $3,119 |
| 2016 | 62 | 39 | None | 24% | $18,645 |
| 2015 | 36 | None | None | 33% | $4,285 |
| 2013 | 46 | 16 | None | None | $2,403 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Creon | 48 | $159,365 | $3,320 |
| Zenpep | 20 | $89,898 | $4,495 |
| Plenvu | 46 | $6,610 | $144 |
| Pantoprazole | 57 | $1,750 | $31 |
| Omeprazole | 31 | $536 | $17 |
| Gavilyte-C | 16 | $347 | $22 |
| Prednisone | 12 | $207 | $17 |
2022: 8 drugs
| Creon | 24 | $136,888 | $5,704 |
| Zenpep | 16 | $52,391 | $3,274 |
| Plenvu | 29 | $3,966 | $137 |
| Ursodiol | 15 | $3,405 | $227 |
| Pantoprazole | 41 | $1,233 | $30 |
| Omeprazole | 32 | $725 | $23 |
| Nortriptyline | 23 | $467 | $20 |
| Gavilyte-C | 24 | $442 | $18 |
2021: 6 drugs
| Creon | 16 | $86,038 | $5,377 |
| Ursodiol | 16 | $4,113 | $257 |
| Plenvu | 21 | $2,650 | $126 |
| Pantoprazole | 70 | $1,864 | $27 |
| Suprep | 12 | $1,419 | $118 |
| Omeprazole | 21 | $675 | $32 |
2020: 4 drugs
| Pantoprazole | 73 | $1,608 | $22 |
| Plenvu | 11 | $1,200 | $109 |
| Omeprazole | 13 | $185 | $14 |
| Amoxicillin-Clavulanate Potass | 16 | $77 | $5 |
2019: 4 drugs
| Dexilant | 11 | $4,734 | $430 |
| Suprep | 35 | $3,459 | $99 |
| Pantoprazole | 77 | $2,062 | $27 |
| Amoxicillin-Clavulanate Potass | 17 | $123 | $7 |
2018: 4 drugs
| Suprep | 25 | $2,495 | $100 |
| Pantoprazole | 55 | $1,121 | $20 |
| Polyethylene Glycol 3350 | 24 | $724 | $30 |
| Amoxicillin-Clavulanate Potass | 15 | $113 | $8 |
2016: 1 drug
| Ciprofloxacin | 20 | $140 | $7 |
Money from drug and device companies
$947 in 2025
| 2025 | 8 | 40 | None | $947 |
| 2024 | 13 | 46 | None | $1,129 |
| 2023 | 13 | 57 | None | $1,312 |
| 2022 | 11 | 100 | None | $3,092 |
| 2021 | 10 | 72 | None | $1,404 |
| 2020 | 10 | 49 | None | $1,023 |
| 2019 | 11 | 29 | None | $735 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $323 | 16 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $241 | 12 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $104 | 4 payments
|
| Janssen Biotech | Tremfya | $92 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $90 | 2 payments
|
| Alnylam Pharmaceuticals | Givlaari | $36 | 1 payment
|
See all 40 published payments
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-19 | Entyvio | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-12-19 | Rezdiffra | $8 |
| Abbvie | Meals · 2025-12-13 | Creon | $19 |
| Abbvie | Meals · 2025-12-09 | Linzess | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-12-05 | Rezdiffra | $21 |
| Abbvie | Meals · 2025-11-18 | Linzess | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-14 | Entyvio | $25 |
| Abbvie | Meals · 2025-11-04 | Linzess | $15 |
| Alnylam Pharmaceuticals | Meals · 2025-10-17 | Givlaari | $36 |
| Abbvie | Meals · 2025-10-10 | Creon | $18 |
| Gilead Sciences | Meals · 2025-09-25 | None | $34 |
| Madrigal Pharmaceuticals | Meals · 2025-09-19 | Rezdiffra | $13 |
| Madrigal Pharmaceuticals | Meals · 2025-09-19 | Rezdiffra | $15 |
| Abbvie | Meals · 2025-09-17 | Linzess | $29 |
| Abbvie | Meals · 2025-09-12 | Creon | $27 |
| Abbvie | Meals · 2025-08-19 | Linzess | $32 |
| Janssen Biotech | Meals · 2025-08-15 | Tremfya | $30 |
| Abbvie | Meals · 2025-08-13 | Creon | $30 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-08 | Entyvio | $27 |
| Aimmune Therapeutics | Meals · 2025-07-28 | Zenpep | $54 |
| Abbvie | Meals · 2025-07-17 | Creon | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-07-10 | Rezdiffra | $33 |
| Abbvie | Meals · 2025-06-05 | Linzess | $13 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-12 | Entyvio | $28 |
| Abbvie | Meals · 2025-05-07 | Linzess | $26 |
| Intercept Pharmaceuticals | Meals · 2025-05-02 | Ocaliva | $26 |
| Madrigal Pharmaceuticals | Meals · 2025-04-11 | Rezdiffra | $39 |
| Abbvie | Meals · 2025-04-09 | Creon | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-04-03 | Rezdiffra | $14 |
| Abbvie | Meals · 2025-03-01 | Linzess | $8 |
| Janssen Biotech | Meals · 2025-02-28 | Tremfya | $28 |
| Abbvie | Meals · 2025-02-15 | Creon | $15 |
| Madrigal Pharmaceuticals | Meals · 2025-02-07 | Rezdiffra | $35 |
| Aimmune Therapeutics | Meals · 2025-02-07 | Vowst | $37 |
| Janssen Biotech | Meals · 2025-01-31 | Tremfya | $35 |
| Madrigal Pharmaceuticals | Meals · 2025-01-30 | Rezdiffra | $3 |
| Madrigal Pharmaceuticals | Meals · 2025-01-30 | Rezdiffra | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-01-29 | Rezdiffra | $2 |
| Madrigal Pharmaceuticals | Meals · 2025-01-18 | Rezdiffra | $35 |
| Abbvie | Meals · 2025-01-17 | Linzess | $11 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,129
| Abbvie | Linzess | $357 | 16 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $145 | 5 payments
|
| Janssen Biotech | Tremfya | $141 | 6 payments
|
| Celltrion USA | Vegzelma | $94 | 5 payments
|
| Lilly USA | Omvoh | $64 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $64 | 3 payments
|
| FUJIFILM Healthcare Americas | Fujifilm | $57 | 1 payment
|
| Aimmune Therapeutics | Zenpep | $48 | 2 payments
|
| Gilead Sciences | None | $45 | 2 payments
|
| Boston Scientific | None | $36 | 1 payment
|
| Axonics | Axonics | $36 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Eohilia | $21 | 1 payment
|
2023: $1,312
| AbbVie | Linzess | $476 | 25 payments
|
| Janssen Biotech | Stelara | $227 | 8 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $174 | 9 payments
|
| Olympus America | Endoclot Phs | $101 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $61 | 3 payments
|
| Celltrion USA | Yuflyma | $53 | 3 payments
|
| Intercept Pharmaceuticals | Ocaliva | $53 | 2 payments
|
| FUJIFILM Healthcare Americas | Fujifilm | $45 | 1 payment
|
| Nestle Healthcare Nutrition | Zenpep | $29 | 1 payment
|
| Ardelyx | Ibsrela | $28 | 1 payment
|
| QOL Medical | Sucraid | $27 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $22 | 1 payment
|
| Celgene | Zeposia | $15 | 1 payment
|
2022: $3,092
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $1,269 | 6 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $896 | 54 payments
|
| Janssen Biotech | Remicade | $300 | 11 payments
|
| Abbvie | Creon | $234 | 15 payments
|
| Endogastric Solutions | Esophyx | $98 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $83 | 3 payments
|
| Ardelyx | Ibsrela | $74 | 3 payments
|
| Celgene | Zeposia | $64 | 3 payments
|
| Nestle HealthCare Nutrition | Zenpep | $37 | 2 payments
|
| RedHill Biopharma | Talicia | $24 | 1 payment
|
| Boston Scientific | Orise | $15 | 1 payment
|
2021: $1,404
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $789 | 48 payments
|
| AbbVie | Creon | $223 | 12 payments
|
| Boston Scientific | Orise | $165 | 2 payments
|
| Gilead Sciences | None | $52 | 2 payments
|
| Nestle HealthCare Nutrition | Zenpep | $49 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $40 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $25 | 1 payment
|
| Daiichi Sankyo | Injectafer | $24 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
| Celgene | Zeposia | $16 | 1 payment
|
2020: $1,023
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $302 | 15 payments
|
| Gilead Sciences | None | $206 | 10 payments
|
| AbbVie | Creon | $171 | 11 payments
|
| Janssen Pharmaceuticals | Invokana | $109 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $91 | 4 payments
|
| Daiichi Sankyo | Injectafer | $62 | 3 payments
|
| Intercept Pharmaceuticals | Ocaliva | $44 | 2 payments
|
| RedHill Biopharma | Aemcolo | $17 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $12 | 1 payment
|
| Ambu | None | $9 | 1 payment
|
2019: $735
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $182 | 10 payments
|
| Gilead Sciences | Vemlidy | $145 | 2 payments
|
| Boston Scientific | Axios | $131 | 1 payment
|
| AbbVie | Mavyret | $118 | 8 payments
|
| Shionogi | Mulpleta | $37 | 2 payments
|
| Ferring Pharmaceuticals | Clenpiq | $26 | 1 payment
|
| Pfizer | Inflectra | $25 | 1 payment
|
| Daiichi Sankyo | Injectafer | $24 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $17 | 1 payment
|
| Allergan | Zenpep | $16 | 1 payment
|
| Braintree Laboratories | Motofen | $14 | 1 payment
|
Professional record
- NPI
- 1407084494
- Licence
- MO 2009015008
- Trained
- Baylor College of Medicine, 2009
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1860 El Camino Real Ste 101, Burlingame, CA, 94010
- NPI first listed
- 2009-06-29
- NPI last updated
- 2019-05-10
This is when the NPI record was last certified, not a medical board exam.